SANOFI (1SAN.MI) Stock Fundamental Analysis
BIT:1SAN - Euronext Milan - FR0000120578 - Common Stock - Currency: EUR
We assign a fundamental rating of 6 out of 10 to 1SAN. 1SAN was compared to 51 industry peers in the Pharmaceuticals industry. While 1SAN belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. 1SAN is not valued too expensively and it also shows a decent growth rate. Finally 1SAN also has an excellent dividend rating. This makes 1SAN very considerable for dividend investing!
1. Profitability
1.1 Basic Checks
1SAN had positive earnings in the past year.
In the past year 1SAN had a positive cash flow from operations.
In the past 5 years 1SAN has always been profitable.
In the past 5 years 1SAN always reported a positive cash flow from operatings.
1.2 Ratios
1SAN has a better Return On Assets (11.05%) than 74.51% of its industry peers.
1SAN has a better Return On Equity (19.73%) than 66.67% of its industry peers.
The Return On Invested Capital of 1SAN (13.84%) is better than 72.55% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for 1SAN is significantly below the industry average of 15.16%.
The 3 year average ROIC (7.31%) for 1SAN is below the current ROIC(13.84%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.05% | ||
| ROE | 19.73% | ||
| ROIC | 13.84% |
ROA(3y)5.02%
ROA(5y)6.2%
ROE(3y)8.55%
ROE(5y)10.84%
ROIC(3y)7.31%
ROIC(5y)7.07%
1.3 Margins
1SAN has a Profit Margin of 20.35%. This is in the better half of the industry: 1SAN outperforms 76.47% of its industry peers.
1SAN's Profit Margin has improved in the last couple of years.
1SAN has a better Operating Margin (23.59%) than 62.75% of its industry peers.
1SAN's Operating Margin has improved in the last couple of years.
1SAN's Gross Margin of 71.70% is in line compared to the rest of the industry. 1SAN outperforms 58.82% of its industry peers.
1SAN's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 23.59% | ||
| PM (TTM) | 20.35% | ||
| GM | 71.7% |
OM growth 3Y-2.73%
OM growth 5Y1.75%
PM growth 3Y-7.54%
PM growth 5Y11.4%
GM growth 3Y0.71%
GM growth 5Y0.58%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), 1SAN is creating value.
Compared to 1 year ago, 1SAN has about the same amount of shares outstanding.
The number of shares outstanding for 1SAN remains at a similar level compared to 5 years ago.
Compared to 1 year ago, 1SAN has an improved debt to assets ratio.
2.2 Solvency
The Debt to FCF ratio of 1SAN is 2.21, which is a good value as it means it would take 1SAN, 2.21 years of fcf income to pay off all of its debts.
1SAN has a better Debt to FCF ratio (2.21) than 82.35% of its industry peers.
1SAN has a Debt/Equity ratio of 0.21. This is a healthy value indicating a solid balance between debt and equity.
1SAN's Debt to Equity ratio of 0.21 is fine compared to the rest of the industry. 1SAN outperforms 72.55% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 2.21 | ||
| Altman-Z | N/A |
ROIC/WACC1.86
WACC7.44%
2.3 Liquidity
A Current Ratio of 1.27 indicates that 1SAN should not have too much problems paying its short term obligations.
1SAN's Current ratio of 1.27 is in line compared to the rest of the industry. 1SAN outperforms 41.18% of its industry peers.
A Quick Ratio of 0.94 indicates that 1SAN may have some problems paying its short term obligations.
1SAN has a Quick ratio of 0.94. This is comparable to the rest of the industry: 1SAN outperforms 45.10% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.27 | ||
| Quick Ratio | 0.94 |
3. Growth
3.1 Past
1SAN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -12.60%.
Measured over the past 5 years, 1SAN shows a small growth in Earnings Per Share. The EPS has been growing by 5.10% on average per year.
1SAN shows a small growth in Revenue. In the last year, the Revenue has grown by 6.45%.
The Revenue has been growing slightly by 3.31% on average over the past years.
EPS 1Y (TTM)-12.6%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%-54.51%
Revenue 1Y (TTM)6.45%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-7.71%
3.2 Future
Based on estimates for the next years, 1SAN will show a small growth in Earnings Per Share. The EPS will grow by 7.73% on average per year.
1SAN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.59% yearly.
EPS Next Y8.37%
EPS Next 2Y9.02%
EPS Next 3Y8.18%
EPS Next 5Y7.73%
Revenue Next Year1%
Revenue Next 2Y3.79%
Revenue Next 3Y4.41%
Revenue Next 5Y4.59%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 12.01 indicates a correct valuation of 1SAN.
Based on the Price/Earnings ratio, 1SAN is valued a bit cheaper than the industry average as 76.47% of the companies are valued more expensively.
1SAN is valuated cheaply when we compare the Price/Earnings ratio to 26.48, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 8.88, the valuation of 1SAN can be described as reasonable.
Based on the Price/Forward Earnings ratio, 1SAN is valued cheaply inside the industry as 82.35% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of 1SAN to the average of the S&P500 Index (34.04), we can say 1SAN is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.01 | ||
| Fwd PE | 8.88 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 1SAN is on the same level as its industry peers.
Based on the Price/Free Cash Flow ratio, 1SAN is valued a bit cheaper than the industry average as 60.78% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.63 | ||
| EV/EBITDA | 10.43 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of 1SAN may justify a higher PE ratio.
PEG (NY)1.43
PEG (5Y)2.36
EPS Next 2Y9.02%
EPS Next 3Y8.18%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 4.85%, 1SAN is a good candidate for dividend investing.
In the last 3 months the price of 1SAN has falen by -23.66%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
1SAN's Dividend Yield is rather good when compared to the industry average which is at 3.14. 1SAN pays more dividend than 84.31% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.40, 1SAN pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.85% |
5.2 History
The dividend of 1SAN has a limited annual growth rate of 4.30%.
Dividend Growth(5Y)4.3%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
34.82% of the earnings are spent on dividend by 1SAN. This is a low number and sustainable payout ratio.
The dividend of 1SAN is growing, but earnings are growing more, so the dividend growth is sustainable.
DP34.82%
EPS Next 2Y9.02%
EPS Next 3Y8.18%
BIT:1SAN (8/8/2025, 7:00:00 PM)
81.07
+0.06 (+0.07%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners40.34%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap197.73B
Analysts80
Price Target108.55 (33.9%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.85% |
Yearly Dividend3.79
Dividend Growth(5Y)4.3%
DP34.82%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-22.81%
Min EPS beat(2)-51.63%
Max EPS beat(2)6.02%
EPS beat(4)2
Avg EPS beat(4)-8.32%
Min EPS beat(4)-51.63%
Max EPS beat(4)14.5%
EPS beat(8)4
Avg EPS beat(8)-4%
EPS beat(12)7
Avg EPS beat(12)-1.41%
EPS beat(16)11
Avg EPS beat(16)0.36%
Revenue beat(2)0
Avg Revenue beat(2)-1.35%
Min Revenue beat(2)-1.4%
Max Revenue beat(2)-1.3%
Revenue beat(4)1
Avg Revenue beat(4)-0.9%
Min Revenue beat(4)-4.57%
Max Revenue beat(4)3.66%
Revenue beat(8)2
Avg Revenue beat(8)-1.22%
Revenue beat(12)5
Avg Revenue beat(12)9.71%
Revenue beat(16)9
Avg Revenue beat(16)21.42%
PT rev (1m)-3.03%
PT rev (3m)-6.09%
EPS NQ rev (1m)-6.81%
EPS NQ rev (3m)-6.81%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-5.75%
Revenue NQ rev (3m)-5.75%
Revenue NY rev (1m)-0.52%
Revenue NY rev (3m)-2.37%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.01 | ||
| Fwd PE | 8.88 | ||
| P/S | 2.91 | ||
| P/FCF | 19.63 | ||
| P/OCF | 17.37 | ||
| P/B | 2.82 | ||
| P/tB | 21.27 | ||
| EV/EBITDA | 10.43 |
EPS(TTM)6.75
EY8.33%
EPS(NY)9.13
Fwd EY11.26%
FCF(TTM)4.13
FCFY5.09%
OCF(TTM)4.67
OCFY5.76%
SpS27.84
BVpS28.7
TBVpS3.81
PEG (NY)1.43
PEG (5Y)2.36
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 11.05% | ||
| ROE | 19.73% | ||
| ROCE | 16.7% | ||
| ROIC | 13.84% | ||
| ROICexc | 16.48% | ||
| ROICexgc | 66.95% | ||
| OM | 23.59% | ||
| PM (TTM) | 20.35% | ||
| GM | 71.7% | ||
| FCFM | 14.83% |
ROA(3y)5.02%
ROA(5y)6.2%
ROE(3y)8.55%
ROE(5y)10.84%
ROIC(3y)7.31%
ROIC(5y)7.07%
ROICexc(3y)8.13%
ROICexc(5y)7.97%
ROICexgc(3y)35.39%
ROICexgc(5y)35.54%
ROCE(3y)8.84%
ROCE(5y)8.55%
ROICexcg growth 3Y-13.63%
ROICexcg growth 5Y-1.43%
ROICexc growth 3Y-1.55%
ROICexc growth 5Y2.05%
OM growth 3Y-2.73%
OM growth 5Y1.75%
PM growth 3Y-7.54%
PM growth 5Y11.4%
GM growth 3Y0.71%
GM growth 5Y0.58%
F-Score7
Asset Turnover0.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 2.21 | ||
| Debt/EBITDA | 0.75 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 58.05% | ||
| Profit Quality | 72.91% | ||
| Current Ratio | 1.27 | ||
| Quick Ratio | 0.94 | ||
| Altman-Z | N/A |
F-Score7
WACC7.44%
ROIC/WACC1.86
Cap/Depr(3y)73.02%
Cap/Depr(5y)67.36%
Cap/Sales(3y)6.35%
Cap/Sales(5y)5.97%
Profit Quality(3y)113.82%
Profit Quality(5y)104.22%
High Growth Momentum
Growth
EPS 1Y (TTM)-12.6%
EPS 3Y5.45%
EPS 5Y5.1%
EPS Q2Q%-54.51%
EPS Next Y8.37%
EPS Next 2Y9.02%
EPS Next 3Y8.18%
EPS Next 5Y7.73%
Revenue 1Y (TTM)6.45%
Revenue growth 3Y4.17%
Revenue growth 5Y3.31%
Sales Q2Q%-7.71%
Revenue Next Year1%
Revenue Next 2Y3.79%
Revenue Next 3Y4.41%
Revenue Next 5Y4.59%
EBIT growth 1Y15.64%
EBIT growth 3Y1.33%
EBIT growth 5Y5.12%
EBIT Next Year34.08%
EBIT Next 3Y14.6%
EBIT Next 5Y10.46%
FCF growth 1Y24.23%
FCF growth 3Y-11.46%
FCF growth 5Y-0.14%
OCF growth 1Y10.87%
OCF growth 3Y-4.79%
OCF growth 5Y3.31%